Treating Venous thromboembolism with rivaroxaban

Kuritzky, Louis
March 2011
Internal Medicine Alert;2/28/2011 Supplement, p32
The article reports on a study which discovers the effectiveness of oral rivaroxaban in treating venous thromboembolism.


Related Articles

  • Long-term anticoagulation means fewer recurrences of venous thromboembolism.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p12 

    Reports on a significant reduction in the incidence of recurrent venous thromboembolism when the duration of oral anticoagulant therapy was extended from 6 weeks to 6 months. Study published in the June 22, 1995, issue of `The New England Journal of Medicine'.

  • Treatment options for acute venous thromboembolism in the older patient. Rostagno, Carlo; Caciolli, Sabina; Gensini, Gian Franco // Geriatrics;Jan98, Vol. 53 Issue 1, p34 

    Suggests treatment options for patients with acute venous thromboembolism. Examination of risk factors of thromboembolism; Details on a community study conducted in Massachusetts; Discussion on findings; Suggestions made for treatment of thromboembolism.

  • Management of Venous Thromboembolism. Ginsberg, Jeffrey Stephen // New England Journal of Medicine;12/12/96, Vol. 335 Issue 24, p1816 

    Presents a review article dealing with the care of patients with venous thromboembolism, with emphasis on recent advances. Diagnosis; Thrombophilia; Treatment; Management of complications; Venous thromboembolism during pregnancy; Inferior vena caval filters and surgical thrombectomy;...

  • Thromboembolism plan.  // Pulse;1/12/2011, Vol. 71 Issue 1, p9 

    The article offers information concerning the advisory issued from the Scottish Intercollegiate Guidelines Network concerning the prevention and treatment of venous thromboembolism in Great Britain.

  • VTE prevention and treatment study launches in Europe. Lyon, Sue // British Journal of Hospital Medicine (17508460);Mar2010, Vol. 71 Issue 3, p129 

    The article reports on the launch of HOKUSAI-VTE, the venous thromboembolism (VTE) prevention and study, in Europe.

  • Improving uptake of prophylaxis for venous thromboembolism in general surgical patients using... Byrne, Ged J.; Silverman, Stanley H. // BMJ: British Medical Journal (International Edition);10/12/96, Vol. 313 Issue 7062, p917 

    Assesses the uptake of venous thromboembolism prophylaxis through an audit of general surgical inpatients in a busy district general hospital. Provision of an A4 sized protocol sheet; Oral and written protocols as an accepted method of correcting deficiencies.

  • Low molecular weight heparins for arterial thrombosis. Nenci, G.G.; Minciotti, A. // Vascular Medicine;2000, Vol. 5 Issue 4, p251 

    The use of low molecular weight heparin (LMWH) for the prevention and treatment of venous thromboembolism has been validated by numerous clinical trials and meta-analyses over the past 25 years. More recently, the possibility of extending treatment with LMWH to the arterial disease where...

  • A Survey of Physicians' Knowledge and Management of Venous Thromboembolism. Zierler, Brenda K.; Meissner, Mark H.; Cain, Kevin; Strandness, D. Eugene // Vascular & Endovascular Surgery;Sep/Oct2002, Vol. 36 Issue 5, p367 

    Presents a survey on the knowledge and management strategies of physicians in dealing with venous thromboembolism (VTE). Response of physicians to ranges of charges for VTE diagnostic tests; Treatment of VTE; Development of an integrated care pathway for the diagnosis of VTE to address...

  • To prevent thromboembolism, give oral anticoagulants for 6 months, not 6 weeks.  // Modern Medicine;Oct95, Vol. 63 Issue 10, p50 

    Presents an abstract of the article `A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism,' by S. Schulman, A.-S. Rhedin, P. Lindmarker, et al from the `New England Journal of Medicine' dated June 22, 1995.

  • Any questions? Meade, T.W. // BMJ: British Medical Journal (International Edition);4/29/95, Vol. 310 Issue 6987, p1118 

    Discusses the rationale of using a combination of aspirin and warfarin in thromboembolic conditions. Expected effect on the risk of serious bleeding; Possible lowering of the risk of major cardiac episodes in patients with unstable angina or non-Q wave infarction; Precautions to be observed.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics